Navigation Links
Fujirebio in Medical News

New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer

... vice president, research and development, Abbott Diagnostics. "HE4 represents an important advancement in monitoring these pelvic masses." fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to develop this new ovarian cancer marker for use on Abbott's automated ARCHITECT(R) diag...

Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer

... MALVERN, Pa., March 23 /PRNewswire/ -- fujirebio Diagnostics, Inc., the premier cancer diagnostics ... as Chief Scientific Officer. Dr. Barnes comes to fujirebio Diagnostics with 25 years of diagnostics experienc...product candidates and licensing opportunities for fujirebio Diagnostics products. "Dr. Barnes' extensiv...

Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer

... the biomarkers HE4 and CA125 along with ROMA, the fujirebio Diagnostics test appears to be more sensitive than... 72 women will develop ovarian cancer. About fujirebio Diagnostics, Inc. fujirebio Diagnostics is the premier cancer diagnostics comp...

Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers

...Pa. and Abbott Park, Ill., Jan. 27 /PRNewswire/ -- fujirebio Diagnostics, Inc. and Abbott have signed a license...TECT(R) diagnostic analyzers. Under the agreement, fujirebio Diagnostics will develop and manufacture for Abbot...h.D., vice president and chief scientific officer, fujirebio Diagnostics. "The HE4 test, which is expected to b...

Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test

... fujirebio Diagnostics' HE4 Test will be Available Through Ro... Pa. and Basel, SwitzerlandDec. 16 /PRNewswire/ -- fujirebio Diagnostics, Inc. and Roche Diagnostics announced ...reement, Roche will develop an assay kit utilizing fujirebio Diagnostics' HE4 test on its automated immunoassay...

Vascular Solutions CEO Elected to MDMA Board of Directors

...f Alta Partners; Jo Ellen Slurzberg of Almyra, Inc.; Mark Sieczkerek of Conceptus, Inc.; Thomas Thompson of Neuro Resource Group (NRG); Paul Touhey of fujirebio Diagnostics, Inc.; Russ Trenary of Advanced Medical Optics (AMO) and Mark Wan of Three Arch Partners. As founder of Vascular Solutions in 1997, Root...

Malignant tumor or benign cyst?

...on, vice president and chief scientific officer of fujirebio Diagnostics, the developers of the CA 125 test. As...eventually lead to a plausible screening tool. fujirebio Diagnostics has developed a manual test for HE4 an...ll be developing automated formats of the test for fujirebio instruments. The HE4 test is CE marked in Europe. ...
Fujirebio in Medical Technology

Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass

... Article in Gynecologic Oncology Supports Use of fujirebio Diagnostics' HE4 Test with CA125 for Risk Strati...ic Oncology demonstrated the utility of combining fujirebio Diagnostics' HE4 and the CA125 test as an aid in e...ses are diagnosed in the early stages. About fujirebio Diagnostics ...
Fujirebio in Medical Products

Cancer Antigen 125 (Trademark of Fujirebio Diagnostic Inc.)

Description: Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
Company:Abbott Diagnostics
Fujirebio in Biological Technology

BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

Alliance Aims to First Develop Powerful Tools for Detecting Ovarian Cancer Earlier FRANKLIN LAKES, N.J. and MALVERN, Pa., May 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) and Fujirebio Diagnostics, Inc., announced today the signing of a worldwide development ...

Fujirebio Diagnostics Named One of the Best Places to Work in Pennsylvania

...d companies MALVERN, Pa., Oct. 6 /PRNewswire/ -- fujirebio Diagnostics, Inc., a Malvern-based company, was re...e state's economy, its workforce and businesses. fujirebio Diagnostics, the premier cancer diagnostics compan...marker assays, employs 125 people in Pennsylvania. fujirebio Diagnostics specializes in the clinical developmen...
Other Tags
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... InHealth Media. Nutritional Products International and InHealth media is a global sales and ... , “We are extremely pleased to continue our business relationship with Mr. Reid Eckert, ...
(Date:8/30/2015)... ... 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ) ... Assistant to CEO Mitch Gould for Nutritional Products International. Through all methods ... Kathleen graduated from Florida State University with a Bachelor of Science in Business ...
(Date:8/29/2015)... ... ... Rio Salado College President Chris Bustamante announced on Aug. 19 ... Initiatives and Information Services. O’Shea, who has served Rio Salado for the last two ... through innovative technologies and strategies. , “I am very proud to be able to ...
(Date:8/29/2015)... ... August 30, 2015 , ... Electronic ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact ... handwritten signature. , Clinical trial sites can now use audio, video ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... inventors from Miller Place, N.Y. "I specialize in manual therapy, and my invention ... it can be used for additional muscle dysfunction throughout the body." , They ...
Breaking Medicine News(10 mins):Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
Other Contents